Literature DB >> 20466783

Reduced oxygenation in human obese adipose tissue is associated with impaired insulin suppression of lipolysis.

Magdalena Pasarica1, Jennifer Rood, Eric Ravussin, Jean-Marc Schwarz, Steven R Smith, Leanne M Redman.   

Abstract

CONTEXT: Adipose tissue in obese individuals is characterized by reduced capillary density and reduced oxygenation.
OBJECTIVE: Our objective was to test whether hypoxia is associated with reduced antilipolytic effect of insulin. PARTICIPANTS, DESIGN, AND
SETTING: Twenty-one lean and obese individuals participated in this cross-sectional study at a university-based clinical research center. INTERVENTION: In all subjects, in situ adipose tissue (AT) oxygenation [AT oxygen partial pressure (ATpO2)] was measured with a Clark electrode, insulin sensitivity as well as basal and insulin-suppressed lipolysis (continuous infusion of (2H5)glycerol) were measured during a euglycemic-hyperinsulinemic clamp, and abdominal sc AT biopsies were collected to assess fat cell size (Coulter counting of osmium-fixed cells), capillary density (by staining of histological sections), and gene expression (by quantitative RT-PCR). MAIN OUTCOME MEASURE: In situ ATpO2 was evaluated.
RESULTS: The ability of insulin to suppress lipolysis (percent) was positively correlated with insulin sensitivity (r=0.43; P<0.05), ATpO2 (r=0.44; P<0.05), vascular endothelial growth factor mRNA (r=0.73; P<0.01), and capillary density (r=0.75; P<0.01).
CONCLUSION: These results indicate that low capillary density and ATpO2 in AT are potentially upstream causes of AT dysfunction.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20466783      PMCID: PMC2913036          DOI: 10.1210/jc.2009-2377

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  14 in total

Review 1.  Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach.

Authors:  Harold Bays; Lawrence Mandarino; Ralph A DeFronzo
Journal:  J Clin Endocrinol Metab       Date:  2004-02       Impact factor: 5.958

2.  Free fatty acids and atherosclerosis--guilty or innocent?

Authors:  Steven R Smith; Peter W F Wilson
Journal:  J Clin Endocrinol Metab       Date:  2006-07       Impact factor: 5.958

Review 3.  Thematic review series: patient-oriented research. Free fatty acid metabolism in human obesity.

Authors:  Christina Koutsari; Michael D Jensen
Journal:  J Lipid Res       Date:  2006-05-09       Impact factor: 5.922

Review 4.  The adipose-tissue renin-angiotensin-aldosterone system: role in the metabolic syndrome?

Authors:  Stefan Engeli; Petra Schling; Kerstin Gorzelniak; Michael Boschmann; Jürgen Janke; Gérard Ailhaud; Michèle Teboul; Florence Massiéra; Arya M Sharma
Journal:  Int J Biochem Cell Biol       Date:  2003-06       Impact factor: 5.085

5.  Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance.

Authors:  Haiyan Xu; Glenn T Barnes; Qing Yang; Guo Tan; Daseng Yang; Chieh J Chou; Jason Sole; Andrew Nichols; Jeffrey S Ross; Louis A Tartaglia; Hong Chen
Journal:  J Clin Invest       Date:  2003-12       Impact factor: 14.808

6.  Pathogenesis of NIDDM. A balanced overview.

Authors:  R A DeFronzo; R C Bonadonna; E Ferrannini
Journal:  Diabetes Care       Date:  1992-03       Impact factor: 19.112

Review 7.  Adipokines: inflammation and the pleiotropic role of white adipose tissue.

Authors:  Paul Trayhurn; I Stuart Wood
Journal:  Br J Nutr       Date:  2004-09       Impact factor: 3.718

8.  Methods for the determination of adipose cell size in man and animals.

Authors:  J Hirsch; E Gallian
Journal:  J Lipid Res       Date:  1968-01       Impact factor: 5.922

9.  Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity.

Authors:  Utpal B Pajvani; Meredith Hawkins; Terry P Combs; Michael W Rajala; Tom Doebber; Joel P Berger; John A Wagner; Margaret Wu; Annemie Knopps; Anny H Xiang; Kristina M Utzschneider; Steven E Kahn; Jerrold M Olefsky; Thomas A Buchanan; Philipp E Scherer
Journal:  J Biol Chem       Date:  2003-12-29       Impact factor: 5.157

10.  Reduced adipose tissue oxygenation in human obesity: evidence for rarefaction, macrophage chemotaxis, and inflammation without an angiogenic response.

Authors:  Magdalena Pasarica; Olga R Sereda; Leanne M Redman; Diana C Albarado; David T Hymel; Laura E Roan; Jennifer C Rood; David H Burk; Steven R Smith
Journal:  Diabetes       Date:  2008-12-15       Impact factor: 9.461

View more
  34 in total

1.  Tensions rise and blood flows over dysfunctional fat.

Authors:  Silvia Corvera; Michael P Czech
Journal:  Circulation       Date:  2011-07-05       Impact factor: 29.690

2.  Decreased adipose tissue oxygenation associates with insulin resistance in individuals with obesity.

Authors:  Vincenza Cifarelli; Scott C Beeman; Gordon I Smith; Jun Yoshino; Darya Morozov; Joseph W Beals; Brandon D Kayser; Jeramie D Watrous; Mohit Jain; Bruce W Patterson; Samuel Klein
Journal:  J Clin Invest       Date:  2020-12-01       Impact factor: 14.808

Review 3.  Visceral adiposopathy: a vascular perspective.

Authors:  Melissa G Farb; Noyan Gokce
Journal:  Horm Mol Biol Clin Investig       Date:  2015-02

Review 4.  Adipokines: a link between obesity and cardiovascular disease.

Authors:  Kazuto Nakamura; José J Fuster; Kenneth Walsh
Journal:  J Cardiol       Date:  2013-12-16       Impact factor: 3.159

Review 5.  Murine models of sleep apnea: functional implications of altered macrophage polarity and epigenetic modifications in adipose and vascular tissues.

Authors:  Wojciech Trzepizur; Rene Cortese; David Gozal
Journal:  Metabolism       Date:  2017-11-16       Impact factor: 8.694

Review 6.  Type 2 diabetes as an inflammatory disease.

Authors:  Marc Y Donath; Steven E Shoelson
Journal:  Nat Rev Immunol       Date:  2011-01-14       Impact factor: 53.106

7.  Antiangiogenic actions of vascular endothelial growth factor-A165b, an inhibitory isoform of vascular endothelial growth factor-A, in human obesity.

Authors:  Doan T M Ngo; Melissa G Farb; Ryosuke Kikuchi; Shakun Karki; Stephanie Tiwari; Sherman J Bigornia; David O Bates; Michael P LaValley; Naomi M Hamburg; Joseph A Vita; Donald T Hess; Kenneth Walsh; Noyan Gokce
Journal:  Circulation       Date:  2014-08-12       Impact factor: 29.690

8.  Control of adipose tissue expandability in response to high fat diet by the insulin-like growth factor-binding protein-4.

Authors:  Olga Gealekman; Kunal Gurav; My Chouinard; Juerg Straubhaar; Michael Thompson; Samir Malkani; Celia Hartigan; Silvia Corvera
Journal:  J Biol Chem       Date:  2014-04-28       Impact factor: 5.157

9.  Regulation of thrombospondin-1 expression in alternatively activated macrophages and adipocytes: role of cellular cross talk and omega-3 fatty acids.

Authors:  Brian S Finlin; Beibei Zhu; Catherine P Starnes; Robert E McGehee; Charlotte A Peterson; Philip A Kern
Journal:  J Nutr Biochem       Date:  2013-03-22       Impact factor: 6.048

Review 10.  Hypoxia-regulated mechanisms in the pathogenesis of obesity and non-alcoholic fatty liver disease.

Authors:  Sander Lefere; Christophe Van Steenkiste; Xavier Verhelst; Hans Van Vlierberghe; Lindsey Devisscher; Anja Geerts
Journal:  Cell Mol Life Sci       Date:  2016-04-18       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.